Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Main Sequence Ventures has returned for a $10m series B round that will drive Kasada's expansion efforts following its opening of headquarters in the US.

Ona Therapeutics is working on treatments for metastatic cancer and has collected series A funding from investors including Bpifrance.

Material Impact has participated in a series C1 round for Zero Mass Water, the ASU spinout that has created a system to convert air and sunlight to drinking water.

The universities of Edinburgh, Manchester, Glasgow and Aberdeen have all contributed to Epidarex’s latest fund, which will invest in life sciences spinouts.

Kaiser Permanente contributed to a round that pushed the total raised by the Stanford-aligned cellular cancer therapy developer to $300m.

MIT Media Lab's E14 fund has contributed to a round that will fund research and development for the logistics management platform developer.

Rutgers University-New Brunswick has spun out Infinity Biologix with backing from Viking Global Investors to manage the distribution of a saliva-based coronavirus test.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

TU Delft and Imperial-founded genetic data analytics software provider BlueBee has been picked up after raising at least $13.5m of funding.